877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Drugs for benign prostatic hyperplasia

Categories

Drugs acting on the genito-urinary system (58)
Urologicals (58)
Alpha blockers (55)
Antihypertensive agents (55)
Drugs acting on the cardiovascular system (55)
Drugs acting on the nervous system (29)
Psychoactive drugs (29)
Cyclic compounds (28)
Pharmaceuticals (22)
Alpha-1 blockers (18)
Antihistamines (15)
Six-membered rings (15)
Alpha-2 blockers (13)
Five-membered rings (13)
H1 receptor antagonists (13)
Aromatic compounds (12)
Psychopharmacology (11)
Piperazines (8)
Dopamine antagonists (7)
Imidazolines (7)
Piperidines (7)
Antidepressants (6)
Antipsychotics (6)
Cardiovascular system drug (6)
Organic compound (6)
Antihypertensive agent (5)
Antiparkinsonian agents (5)
Dopamine agonists (5)
Fluoroarenes (5)
Benzodioxins (4)
D2 antagonists (4)
Nervous system drug (4)
Psychoanaleptics (4)
Tetracyclic antidepressants (4)
Atypical antipsychotics (3)
Erectile dysfunction drugs (3)
Halides (3)
Hormonal agents (3)
Ketones (3)
Noradrenergic and specific serotonergic antidepressants (3)
Organohalides (3)
Sex hormones (3)
Sexual dysfunction drugs (3)
Systemic hormonal preparations (3)
Analgesic (2)
Analgesics (2)
Antiandrogens (2)
Antimigraine drugs (2)
Antineoplastic and immunomodulating drugs (2)
Anxiolytics (2)
Chloroarenes (2)
D3 antagonists (2)
Genito-urinary system drug (2)
Heterocyclic compounds (2)
Heterocyclic compounds (4 or more rings) (2)
Organochlorides (2)
Phenethylamines (2)
Polycyclic organic compounds (2)
Progestogens (2)
Pyrimidines (2)
Tetrahydrofurans (2)
Typical antipsychotics (2)
Vasodilators (2)
Anti-inflammatory agents (1)
Anti-inflammatory and antirheumatic products (1)
Antianginals (1)
Antiarrhythmic agents (1)
Antidementia agents (1)
Antigonadotropins (1)
Antineoplastic drugs (1)
Aromatic ketones (1)
Beta blockers (1)
Bromoarenes (1)
Chalcogenides (1)
D1 antagonists (1)
D2-receptor agonists (1)
D3 receptor agonists (1)
D4 antagonists (1)
Designer drugs (1)
Disulfiram-like drugs (1)
Drugs acting on the musculoskeletal system (1)
Ethers (1)
Euphoriants (1)
Furans (1)
Glucocorticoids (1)
Hormonal antineoplastic drugs (1)
Immunomodulating drugs (1)
Immunosuppressants (1)
Isoxazoles (1)
Monoamine releasing agents (1)
Mood stabilizers (1)
Organobromides (1)
Oxadiazoles (1)
Progestogen esters (1)
Psycholeptics (1)
Serotonin-norepinephrine-dopamine releasing agents (1)
Stimulants (1)
Sulfides (1)
Tetrazoles (1)

Suppliers

Sigma Aldrich (10)
TCI Chemicals (7)
AK Scientific (6)
Matrix Scientific (4)
Toronto Research Chemicals (3)
Oakwood Chemical (2)
Accela (1)
Apollo Scientific (1)
Frontier Scientific (1)
SynQuest Laboratories (1)

Aripiprazole (129722-12-9)  
Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. From April 2013 to March 2014, sales of Abilify amounted to almost $6.9 billion.. It is recommended by some doctors and used in the treatment of schizophrenia and bipolar disorder.
Risperidone (106266-06-2)  
Risperidone, sold under the trade name Risperdal among others, is an antipsychotic medication. It is mainly used to treat schizophrenia, bipolar disorder, and irritability in people with autism. It is taken either by mouth or by injection into a muscle.
TAMSULOSIN (106133-20-4)  
Tamsulosin, sold under the trade name Alna ® / Flomax ®, is a medication used to treat symptomatic benign prostatic hyperplasia (BPH), help with the passage of kidney stones, and for urinary retention along with other measures. Tamsulosin, and other medications in the class called alpha blockers, work by relaxing bladder neck muscles and muscle fibers in the prostate itself and make it easier to urinate. It is an α1a adrenergic receptor antagonist.
apomorphine (58-00-4, 314-19-2, 41372-20-7)  
Apomorphine Hydrochloride  ·  Apomorphin Teclapharm  ·  Hemihydrate Apomorphine Hydrochloride
Apomorphine (brand names Apokyn, Ixense, Spontane, Uprima) is a type of aporphine having activity as a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product by boiling with concentrated acid, hence the -morphine suffix.
prazosin (19216-56-9)  
Minipress  ·  Prazosin Hydrochloride  ·  Prazosin HCL
Prazosin, trade names Minipress, Vasoflex, Lentopres and Hypovase, is a sympatholytic drug used to treat high blood pressure, anxiety, and posttraumatic stress disorder (PTSD). It is an α1-blocker which acts as an inverse agonist at alpha-1 adrenergic receptors. These receptors are found on vascular smooth muscle, where they are responsible for the vasoconstrictive action of norepinephrine.
phenoxybenzamine (59-96-1)  
Dibenzyline  ·  Phenoxybenzamine Hydrochloride  ·  Dibenyline
Phenoxybenzamine (marketed under the trade name Dibenzyline) is a non-selective, irreversible alpha blocker.
mirtazapine (61337-67-5, 85650-52-8)  
Remeron  ·  Rexer  ·  ORG 3770
Mirtazapine, sold under the brand name Remeron among others, is an atypical antidepressant which is used primarily in the treatment of depression. In addition to its antidepressant properties, mirtazapine has anxiolytic, sedative, antiemetic, and appetite stimulant effects and is sometimes used in the treatment of anxiety disorders, insomnia, nausea and vomiting, and to produce weight gain when desirable. It is taken by mouth.
alfuzosin (81403-80-7)  
Urion  ·  UroXatral  ·  alfuzosin hydrochloride
Alfuzosin (INN, provided as the hydrochloride salt) is a pharmaceutical drug of the α1 blocker class. As an antagonist of the α1 adrenergic receptor, it works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. It is thus used to treat benign prostatic hyperplasia (BPH).
phentolamine (50-60-2)  
Regitine  ·  Phentolamine Mesylate  ·  Rogitine
Phentolamine (Regitine) is a reversible nonselective α-adrenergic antagonist.
terazosin (63590-64-7)  
Terazosin (marketed as Hytrin or Zayasel) is a selective alpha-1 antagonist used for treatment of symptoms of an enlarged prostate (BPH). It also acts to lower the blood pressure, and is therefore a drug of choice for men with hypertension and prostate enlargement. It is available in 1 mg, 2 mg, 5 mg or 10 mg doses.
doxazosin (74191-85-8)  
Cardura  ·  Doxazosin Mesylate  ·  Progandol Neo
Doxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura and Carduran, is an α1-selective alpha blocker used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia (BPH). In March 2000, the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) study stopped its arm of the trial looking at alpha blockers, because doxazosin was less effective than a simple diuretic, and because patients on doxazosin had a 25% higher rate of cardiovascular disease and twice the rate of congestive heart failure as patients on diuretics. Pfizer, aware of the results before publication, launched a marketing campaign in early 2000, and sales were largely unaffected, despite the dangers highlighted by the study.
ethopropazine (522-00-9, 1094-08-2)  
Parsidol  ·  ethopropazine hydrochloride  ·  profenamine
Profenamine (INN, trade names Parsidol, Parsidan, Parkin), also known as ethopropazine (BAN), is a phenothiazine derivative used as an antiparkinsonian agent that has anticholinergic, antihistamine, and antiadrenergic actions. It is also used in the alleviation of the extrapyramidal syndrome induced by drugs such as other phenothiazine compounds, but, like other compounds with antimuscarinic properties, is of no value against tardive dyskinesia.
Esmirtazapine (61337-87-9)  
mirtazapine  ·  Remeron  ·  Rexer
Esmirtazapine (ORG-50,081) is a drug which was under development by Organon for the treatment of insomnia and vasomotor symptoms (e.g., hot flashes) associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses similar overall pharmacology, including inverse agonist actions at H1 and 5-HT2 receptors and antagonist actions at α2-adrenergic receptors. As of March 2010, Merck terminated internal clinical development program for esmirtazapine, for hot flashes and insomnia, for strategic reasons.
nicergoline (27848-84-6)  
Nicergolin neuraxpharm  ·  ergobel  ·  Krewel Brand of Nicergoline
Nicergoline (INN, marketed under the trade name Sermion) is an ergot derivative used to treat senile dementia and other disorders with vascular origins. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells. It has similar vasoactive properties in other areas of the body, particularly the lungs.
Ketanserin (83846-83-7, 74050-98-9)  
R 41468  ·  R-41468  ·  R-41,468
Ketanserin (INN, USAN, BAN) (brand name Sufrexal; former developmental code name R41468) is a drug used clinically as an antihypertensive agent and in scientific research to study the serotonin system; specifically, the 5-HT2 receptor family. It was discovered at Janssen Pharmaceutica in 1980.
Pipamperone (1893-33-0)  
R 3345  ·  Dipiperon  ·  1'-(3-(4-fluorobenzoyl)propyl)-(1,4'-bipiperidine) -4'-carboxamide
Pipamperone (INN, USAN, BAN), also known as carpiperone and floropipamide or fluoropipamide, and as floropipamide hydrochloride (JAN), is a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia. It is or has been marketed under brand names including Dipiperon, Dipiperal, Piperonil, Piperonyl, and Propitan. Pipamperone was discovered at Janssen Pharmaceutica in 1961, and entered clinical trials in the United States in 1963.
MELPERONE (3575-80-2)  
Melperone (Bunil (PT), Buronil (AT, BE, CZ, DK, FL†, NL†, NO†, SE), Eunerpan (DE)) is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. It first entered clinical use in 1960s.
piribedil (3605-01-4)  
ET 495  ·  Trivastal  ·  Piribedil Mesylate
Piribedil (trade names Pronoran, Trivastal Retard, Trastal, Trivastan, Clarium and others) is an antiparkinsonian agent and piperazine derivative which acts as a D2 and D3 receptor agonist. It also has α2-adrenergic antagonist properties.
2-(1-Piperazinyl)pyrimidine (125523-53-7, 20980-22-7)  
MJ-13653  ·  1-(2-pyrimidinyl)piperazine  ·  MJ 13653
1-(2-Pyrimidinyl)piperazine (1-PP, 1-PmP) is a chemical compound and piperazine derivative. It is known to act as an antagonist of the α2-adrenergic receptor (Ki = 7.3–40 nM) and, to a much lesser extent, as a partial agonist of the 5-HT1A receptor (Ki = 414 nM; Emax = 54%). It has negligible affinity for the dopamine D2, D3, and D4 receptors (Ki > 10,000 nM) and does not appear to have significant affinity for the α1-adrenergic receptors.
Next Page >